Literature DB >> 10780973

Suppression of apoptosis by glucocorticoids in glomerular endothelial cells: effects on proapoptotic pathways.

U K Messmer1, G Winkel, V A Briner, J Pfeilschifter.   

Abstract

Tumour necrosis factor-alpha (TNF-alpha)- and lipopolysaccharide (LPS)-induced apoptosis of bovine glomerular endothelial cells is now recognized as an important part in the pathogenesis of glomerulonephritis characterized by early mitochondrial cytochrome c release, mitochondrial permeability transition, Bak protein upregulation, Bcl-X(L) protein downregulation and caspase-3 activation. Co-treatment of cells with 10 nM dexamethasone and TNF-alpha or LPS blocked roughly 90% of apoptotic cell death in glomerular endothelial cells. The action of glucocorticoids could be documented in that they prevented all apoptotic markers such as DNA laddering, DNA fragmentation measured by the diphenylamine assay as well as morphological alterations. To mechanistically elucidate the action of glucocorticoids we evaluated whether glucocorticoids elicit a time-dependent effect. For dexamethasone, to maximally inhibit DNA fragmentation a preincubation period was not required. Even if dexamethasone was supplemented 6 h following TNF-alpha or LPS we observed a maximal inhibitory effect. Concerning its influence on TNF-alpha and LPS signal transduction, we found that dexamethasone only partially prevented cytochrome-c-release as a first sign of apoptotic cell death but efficiently blocked mitochondrial permeability transition. Moreover, TNF-alpha- and LPS-induced Bak upregulation, Bcl-X(L)-downregulation, and the activation of caspase-3-like proteases, measured fluorometrically using DEVD-AMC and PARP cleavage, were efficiently blocked by dexamethasone. We postulate that glucocorticoids exert their inhibitory action upstream of the terminal death pathways but downstream of primary receptor mediated signals by blocking pro-apoptotic signals pre- and/or post cytochrome c release and mitochondrial signalling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780973      PMCID: PMC1572011          DOI: 10.1038/sj.bjp.0703255

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

1.  Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications.

Authors:  P X Petit; J E O'Connor; D Grunwald; S C Brown
Journal:  Eur J Biochem       Date:  1990-12-12

Review 2.  Genes that regulate apoptosis in the mouse thymus.

Authors:  B A Osborne; S W Smith; K A McLaughlin; L Grimm; T Kallinch; Z Liu; L M Schwartz
Journal:  J Cell Biochem       Date:  1996-01       Impact factor: 4.429

3.  Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-gamma and Fas.

Authors:  L P Wen; K Madani; J A Fahrni; S R Duncan; G D Rosen
Journal:  Am J Physiol       Date:  1997-11

Review 4.  The nature of renal cell injury.

Authors:  C L Edelstein; H Ling; R W Schrier
Journal:  Kidney Int       Date:  1997-05       Impact factor: 10.612

5.  Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis.

Authors:  A Shimizu; H Kitamura; Y Masuda; M Ishizaki; Y Sugisaki; N Yamanaka
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

6.  Bcl-2 protects macrophages from nitric oxide-induced apoptosis.

Authors:  U K Messmer; U K Reed; B Brüne
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

7.  Dexamethasone-induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis.

Authors:  G Cox; R C Austin
Journal:  J Leukoc Biol       Date:  1997-02       Impact factor: 4.962

8.  Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

Authors:  P Li; D Nijhawan; I Budihardjo; S M Srinivasula; M Ahmad; E S Alnemri; X Wang
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

Review 9.  Early events in TNF signaling: a story of associations and dissociations.

Authors:  B G Darnay; B B Aggarwal
Journal:  J Leukoc Biol       Date:  1997-05       Impact factor: 4.962

10.  Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

Authors:  N Auphan; J A DiDonato; C Rosette; A Helmberg; M Karin
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

View more
  10 in total

1.  Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells.

Authors:  U K Messmer; C Pereda-Fernandez; M Manderscheid; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Loss of TIMP3 enhances interstitial nephritis and fibrosis.

Authors:  Zamaneh Kassiri; Gavin Y Oudit; Vijay Kandalam; Ahmed Awad; Xiuhua Wang; Xiuhua Ziou; Nobuyo Maeda; Andrew M Herzenberg; James W Scholey
Journal:  J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 10.121

3.  Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury.

Authors:  Hui Bao; Yan Ge; Ai Peng; Rujun Gong
Journal:  Kidney Int       Date:  2015-01-28       Impact factor: 10.612

4.  Prazosin Can Prevent Glucocorticoid Mediated Capillary Rarefaction.

Authors:  Erin R Mandel; Emily C Dunford; Anastassia Trifonova; Ghoncheh Abdifarkosh; Trevor Teich; Michael C Riddell; Tara L Haas
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

5.  The effects of dexamethasone administered during pregnancy on the postpartum spiny mouse ovary.

Authors:  Monika Hułas-Stasiak; Piotr Dobrowolski; Bożena Pawlikowska-Pawlęga; Ewa Tomaszewska; Siemowit Muszyński
Journal:  PLoS One       Date:  2017-08-21       Impact factor: 3.240

Review 6.  Loss of Mitochondrial Control Impacts Renal Health.

Authors:  Swayam Prakash Srivastava; Keizo Kanasaki; Julie E Goodwin
Journal:  Front Pharmacol       Date:  2020-12-09       Impact factor: 5.810

Review 7.  Impact of cholesterol-pathways on breast cancer development, a metabolic landscape.

Authors:  Alina González-Ortiz; Octavio Galindo-Hernández; Gerson N Hernández-Acevedo; Gustavo Hurtado-Ureta; Victor García-González
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

8.  Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword.

Authors:  Amanda L Gruver-Yates; John A Cidlowski
Journal:  Cells       Date:  2013-03-26       Impact factor: 6.600

9.  Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells.

Authors:  Tonatiuh Barrios-García; Vania Gómez-Romero; Ángeles Tecalco-Cruz; Viviana Valadéz-Graham; Alfonso León-Del-Río
Journal:  Mol Genet Metab Rep       Date:  2016-03-22

Review 10.  Role of Endothelial Glucocorticoid Receptor in the Pathogenesis of Kidney Diseases.

Authors:  Jarosław Przybyciński; Sylwester Drożdżal; Leszek Domański; Violetta Dziedziejko; Andrzej Pawlik
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.